Exos TFP Holdings’s M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share MBSC.WS Stock Holding History
Bought
Maintained
Sold
Exos TFP Holdings's MBSC.WS Position: Q3 2023 in Review
Exos TFP Holdings sold out of M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (MBSC.WS) in Q3 2023, closing a stake of 340,281 shares — an estimated $150K sold.
Exos TFP Holdings first reported a position in MBSC.WS in Q4 2022 and held it in 3 quarters. The position peaked at $190K in Q4 2022. 0 funds tracked by Wall St. Rank hold MBSC.WS as of Q3 2023.
- Exos TFP Holdings reported no remaining M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q3 2023 after selling out during the quarter.
- Exos TFP Holdings sold 340,281 M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q3 2023, an estimated $150K.
- Exos TFP Holdings first reported a position in M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q4 2022 and held it in 3 quarters.
- Exos TFP Holdings's M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $190K in Q4 2022.
- 0 funds tracked by Wall St. Rank held M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q3 2023.
Based on Exos TFP Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.